Agios Pharmaceuticals | AGIO - Current Liabilities

Agios Pharmaceuticals reported $62.63M in Current Liabilities for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 62.63M 9.03M
Alnylam Pharmaceuticals ALNY:US USD 767.92M 4.88M
Amgen AMGN:US USD 15.69B 1.36B
Arrowhead Research ARWR:US USD 122.01M 16.84M
Astellas Pharma 4503:JP JPY 705.91B 55.51B
AstraZeneca AZN:LN USD 26.29B 1.44B
Bayer BAYN:GR EUR 35.08B 1.91B
Biogen BIIB:US USD 3.27B 653.6M
Biomarin Pharmaceutical BMRN:US USD 588.88M 67.86M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Daiichi Sankyo 4568:JP JPY 457.07B 28.97B
Exelixis EXEL:US USD 324.36M 22.63M
Gilead Sciences GILD:US USD 11.24B 814M
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
Immunogen IMGN:US USD 121.86M 18.22M
IONIS PHARMACEUT IONS:US USD 311.56M 28.11M
JAZZ PHA JAZZ:US USD 933.19M 120.24M
Mirati Therapeutics MRTX:US USD 159.45M 32.46M
Moderna Inc MRNA:US USD 4.92B 1.88B
Nektar Therapeutics NKTR:US USD 68.2M 15.78M
Novartis NOVN:VX USD 28.66B 496M
Novartis NVS:US USD 28.66B 496M
Puma Biotechnology PBYI:US USD 77.48M 17.5M
Regeneron Pharmaceuticals REGN:US USD 3.85B 969.9M
Roche Holding ROG:VX 27.24B 170M
Sarepta Therapeutics SRPT:US USD 619.6M 16.69M
Seattle Genetics SGEN:US USD 818.4M 92.41M
Vertex Pharmaceuticals VRTX:US USD 2.43B 178.7M
YTE INCY:US USD 1.16B 150.48M